Biogen Inc., US09062X1037

Biogen stock heads into the open after a 0.8 percent rise

Published on 09/14/2026 at 07:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 11, 2026, Biogen stock finished at USD 217.15 on Nasdaq, up 0.8 percent. It traded between USD 214.71 and USD 219.76 on volume of 1.08 million shares, while Nasdaq Futures pointed lower before today's session.

Fotorealistisches Biotech-Labor in Cambridge MA mit Forscherin am Mikroskop und Blick auf den Charles River
Biogen Inc. Neurowissenschaftslabor in Cambridge MA zeigt Forscherin bei Gehirngewebeanalyse unter Mikroskop ISIN US09062X1037, Illustration mit AI erstellt.

Biogen stock closed at USD 217.15 on Nasdaq on September 11, 2026, up 0.8 percent. The move came with a daily range of USD 214.71 to USD 219.76 and volume of 1.08 million shares.

Biogen Inc. (ISIN US09062X1037, Nasdaq: BIIB) finished above the low of the session and below the 52-week high of USD 225.80. The S&P 500 finished the same session lower than the stock's gain, while Nasdaq Futures were down 1.27 percent before today's open.

Biogen is scheduled to take part in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, according to MarketBeat. The same calendar lists next estimated earnings for October 29, 2026.

Today's U.S. economic calendar also includes 51 events, according to Yahoo Finance, which can shape sector sentiment for biotechnology shares.

Disclaimer...

en | US09062X1037 | BIOGEN INC. | boerse | 70097117 | bgmi